onartuzumab
Showing 1 - 9 of 9
Breast Cancer Trial in Worldwide (Onartuzumab, Bevacizumab, Paclitaxel)
Completed
- Breast Cancer
- Onartuzumab
- +4 more
-
Bakersfield, California
- +52 more
Jan 19, 2017
Non-Squamous NSCLC Trial in Worldwide (erlotinib, onartuzumab, )
Completed
- Non-Squamous Non-Small Cell Lung Cancer
- erlotinib
- +2 more
-
Bakersfield, California
- +34 more
Nov 1, 2016
Non-Squamous NSCLC Trial in Worldwide (Placebo, cisplatin/carboplatin, onartuzumab)
Completed
- Non-Squamous Non-Small Cell Lung Cancer
- Placebo
- +3 more
-
Huntsville, Alabama
- +68 more
Sep 1, 2016
Lung Cancer Trial in Houston (Onartuzumab, Erlotinib, Paclitaxel)
Withdrawn
- Lung Cancer
- Onartuzumab
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 22, 2014